Sign in to continue:

Wednesday, March 25th, 2026

FS KKR Capital Corp Files Form 8-K: Company Details, Address, and Common Stock Listing on NYSE

FS KKR Capital Corp. Files Regulation FD Disclosure Via Form 8-K

Key Highlights for Investors

  • Form 8-K Filing: FS KKR Capital Corp. (NYSE: FSK) filed a Form 8-K with the U.S. Securities and Exchange Commission (SEC) on March 24, 2026. The filing relates to a Regulation FD Disclosure, which is typically used to ensure that material information is made available to all investors simultaneously.
  • Availability of Investor Presentations: The company announced it will make updated investor presentations available on its website (www.fskkrcapitalcorp.com) before the market opens on March 24, 2026. These presentations can be accessed under the “Events & Presentations” page within the “For Investors” section.
  • No Amendments or Special Communications: The filing is not an amendment and does not constitute written communications pursuant to Rule 425 under the Securities Act, nor is it soliciting material or a pre-commencement communication relating to tender offers. All related checkboxes indicating these points are marked as “false.”
  • Security Details: The company’s common stock continues to trade under the symbol “FSK” on the New York Stock Exchange.
  • Emerging Growth Company Status: FSK is not classified as an emerging growth company.

Potential Price-Sensitive Information

  • Updated Investor Presentations: While the filing itself does not disclose specific financial results or guidance, the announcement that updated investor presentations will be made available is potentially price-sensitive. These presentations often contain updates on company strategy, portfolio performance, forward-looking statements, or management commentary, which could influence investor sentiment and impact FSK’s share price once released.
  • Forward-Looking Statements: The company cautions that the Form 8-K may contain forward-looking statements about future events or the company’s performance. Such statements are subject to risks including economic changes, operational disruptions, regulatory changes, and other uncertainties. Investors should be aware that actual results may differ materially from the projections.

What Should Shareholders Know?

  • Monitor the Company Website: Shareholders are encouraged to review the updated investor presentations when they become available, as these may offer new insights into the company’s outlook, strategic initiatives, or other developments not previously disclosed.
  • No Immediate Action Required: There is no indication of any transaction, merger, acquisition, or material change in operations as of this filing. The main event is the upcoming release of updated presentations.
  • Continued Disclosure Practices: FSK notes that, except as required by law, it is not obligated to update the information in the presentations once released.

Summary Table

Event Date Details
Form 8-K Filing March 24, 2026 Regulation FD Disclosure; updated investor presentations to be made available
Trading Symbol Ongoing FSK (NYSE)
Emerging Growth Company No

Conclusion

While this Form 8-K does not disclose any immediate operational or financial changes, the announcement of new investor presentations could be significant. Investors should closely monitor the company’s website for these updates, as they may contain information that could impact the stock’s valuation.


Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should review the official filings and presentations from FS KKR Capital Corp. and consult with their financial advisors before making investment decisions. The company has made forward-looking statements that involve risks and uncertainties which could cause actual results to differ materially from those anticipated.

View FS KKR Capital Corp Historical chart here



CrowdStrike Falcon Platform: Cloud-Native AI Cybersecurity Solutions, Features, and Competitive Advantages 39–57

CrowdStrike Holdings, Inc. 2026 Annual Report: Key Investor ...

Teledyne Technologies 2025 Annual Report: Business Overview, Financials, and Segment Analysis

Teledyne Technologies 2025 Annual Report: Key Investor Takea...

Pharma-Bio Serv, Inc. 10-Q Report January 31, 2026: Financial Statements, Earnings, and SEC Filing Summary

Pharma-Bio Serv, Inc. Q1 FY2026 Financial Report: Key Insigh...

   Ad